Patents by Inventor Edward Green

Edward Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7803814
    Abstract: The present invention provides a compound of the formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: September 28, 2010
    Assignee: Eli Lilly and Company
    Inventors: Konstantinos Gavardinas, Jonathan Edward Green, Prabhakar Kondaji Jadhav, Donald Paul Matthews
  • Patent number: 7797843
    Abstract: An optical sight comprises an elongate housing defining a light channel. A lens is provided at one end of the light channel and has a partially reflecting surface. A laser diode is energised by a pulsating electric current delivered by a battery powered energising circuit, and the energised laser diode emits light towards the reflecting surface to produce a light spot by direct imaging of the laser diode on the surface. The light spot shall be superimposed on the target when sighting through the light channel from the other end thereof.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: September 21, 2010
    Assignee: GS Development AB
    Inventors: Valerie Anne Scott, Alan Edward Green, Euan Morrison
  • Publication number: 20100190259
    Abstract: The present invention relates to the production of ethanol as a product of bacterial fermentation. In particular this invention relates to a novel method of gene inactivation and gene expression based upon homologous recombination. The method is particularly useful in connection with species of Bacillus such as B. stereothermophilus, B. calvodelox, B. caldotenax, B. thermoglucosidasius, B. coagulans, B. licheniformis, B. thermodenitrificans, and B. caldolyticus.
    Type: Application
    Filed: February 24, 2009
    Publication date: July 29, 2010
    Inventors: Muhammed JAVED, Fiona CUSDIN, Paul MILNER, Edward GREEN
  • Patent number: 7691620
    Abstract: Production of ethanol in a thermophilic bacterium can be achieved by transformation of the bacterium with a heterologous gene encoding pyruvate decarboxylase. The bacterium comprises native alcohol dehydrogenase function and does not comprise a gene encoding a functional lactate dehydrogenase. The bacterium may be grown at elevated temperatures to allow the ethanol to be conveniently removed in a vaporized form from the fermentation medium. Traditional mesophilic microorganisms are incapable of growth at the envisioned elevated temperatures.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: April 6, 2010
    Assignee: Elsworth Biotechnology Limited
    Inventors: Edward Green, Muhammad Javed, Namdar Baghaei-Yazdi
  • Publication number: 20100077011
    Abstract: A machine based tool and associated logic and methodology are used in converting data from an input form to a target form using context dependent conversion rules. In particular, a frame-slot architecture is utilized where a frame represents an intersection between a contextual cue recognized by the machine tool, associated content and related constraint information to specific to that conversion environment, whereas a slot represents an included chunk of information. An exemplary conversion system (400) includes a parser (402) for use in parsing and converting an input stream (403) from a source (404) to provide an output stream (411) in a form for use by a target system (412). To accomplish the desired conversion, the parser (402) uses information from a public schema (406), a private schema (408) and a grammar (410). The public schema (406), private schema (408) and grammar (410) may include conversion rules applicable to less than the whole of a subject matter area including the input stream (403).
    Type: Application
    Filed: May 19, 2009
    Publication date: March 25, 2010
    Inventors: Edward A. Green, Kevin L. Markey, Alee Sharp
  • Publication number: 20100069404
    Abstract: The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly reduced bones mass, osteoporosis, osteopenia, or reduced muscle mass or strength, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof. X-17142.
    Type: Application
    Filed: November 6, 2007
    Publication date: March 18, 2010
    Inventors: Konstantinos Gavardinas, Jonathan Edward Green, Prabhakar Kondaji Jadhav, Donald Paul Matthews
  • Patent number: 7680867
    Abstract: A method and apparatus are disclosed for transforming information from one semantic environment to another. In one implementation, a SOLx system (1700) includes a Normalization/Translation NorTran Workbench (1702) and a SOLx server (1708). The NorTran Workbench (1702) is used to develop a knowledge base based on information from a source system (1712), to normalize legacy content (1710) according to various rules, and to develop a database (1706) of translated content. During run time, the SOLx server (1708) receives transmissions from the source system (1712), normalizes the transmitted content, accesses the database (1706) of translated content and otherwise translates the normalized content, and reconstructs the transmission to provide substantially real-time transformation of electronic messages.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: March 16, 2010
    Assignee: Silver Creek Systems, Inc.
    Inventors: Edward A. Green, Ramon Krosley, Kevin L. Markey
  • Patent number: 7655641
    Abstract: The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: February 2, 2010
    Assignee: Eli Lilly and Company
    Inventors: Scott Eugene Conner, Lynn Stacy Gossett, Jonathan Edward Green, Winton Dennis Jones, Jr., Nathan Bryan Mantlo, Donald Paul Matthews, Daniel Ray Mayhugh, Daryl Lynn Smith, Jennifer Ann Vance, Xiaodong Wang, Alan M Warshawsky, Leonard Larry Winneroski, Jr., Yanping Xu, Guoxin Zhu
  • Publication number: 20100022550
    Abstract: The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of formula (I).
    Type: Application
    Filed: June 21, 2006
    Publication date: January 28, 2010
    Applicant: CELLECTIS
    Inventors: Kevin Robert Fales, Jonathan Edward Green, Prabhakar Kondaji Jadhav, Donald Paul Matthews, David Andrew Neel, Edward C.R. Smith
  • Publication number: 20090291758
    Abstract: One embodiment of the invention provides a method of televising a card game. Each playing card in the card game has a value. The method includes providing the back surface of each playing card with a marking that is substantially invisible to the naked eye. The marking indicates the value of the playing card. An infrared detector is used to access the marking to identify the value of a playing card involved in the card game. Visual information indicative of the identified value of the playing card is generated and included in a broadcast of the card game.
    Type: Application
    Filed: May 30, 2006
    Publication date: November 26, 2009
    Applicant: IKNOWLEDGE LTD.
    Inventors: Kevan Moretti, Nick Bryan, Alan Edward Green, David John Stocks
  • Publication number: 20090281792
    Abstract: A semantic conversion system (1900) includes a self-learning tool (1902). The self-learning tool (1902) receives input files from legacy data systems (1904). The self-learning tool (1902) includes a conversion processor (1914) that can calculate probabilities associated with candidate conversion terms so as to select an appropriate conversion term. The self-learning tool (1902) provides a fully attributed and normalized data set (1908).
    Type: Application
    Filed: January 5, 2009
    Publication date: November 12, 2009
    Applicant: SILVER CREEK SYSTEMS, INC.
    Inventors: EDWARD A. GREEN, KEVIN L. MARKEY
  • Publication number: 20090164428
    Abstract: A semantic conversion system (1900) includes a self-learning tool (1902). The self-learning tool (1902) receives input files from legacy data systems (1904). The self-learning tool (1902) includes a conversion processor (1914) that can calculate probabilities associated with candidate conversion terms so as to select an appropriate conversion term. The self-learning tool (1902) provides a fully attributed and normalized data set (1908).
    Type: Application
    Filed: May 23, 2008
    Publication date: June 25, 2009
    Inventors: Edward A. Green, Kevin L. Markey
  • Publication number: 20090149445
    Abstract: The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula: or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
    Type: Application
    Filed: July 15, 2008
    Publication date: June 11, 2009
    Inventors: Michael Joseph Coghlan, Jonathan Edward Green, Timothy Alan Grese, Prabhakar Kondaji Jadhav, Donald Paul Matthews, Mitchell Irvin Steinberg, Kevin Robert Fales, Michael Gregory Bell
  • Patent number: 7536634
    Abstract: A machine based tool and associated logic and methodology are used in converting data from an input form to a target form using context dependent conversion rules. In particular, a frame-slot architecture is utilized where a frame represents an intersection between a contextual cue recognized by the machine tool, associated content and related constraint information to specific to that conversion environment, whereas a slot represents an included chunk of information. An exemplary conversion system (400) includes a parser (402) for use in parsing and converting an input stream (403) from a source (404) to provide an output stream (411) in a form for use by a target system (412). To accomplish the desired conversion, the parser (402) uses information from a public schema (406), a private schema (408) and a grammar (410). The public schema (406), private schema (408) and grammar (410) may include conversion rules applicable to less than the whole of a subject matter area including the input stream (403).
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: May 19, 2009
    Assignee: Silver Creek Systems, Inc.
    Inventors: Edward A. Green, Kevin L. Markey, Alec Sharp
  • Patent number: 7482344
    Abstract: The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: January 27, 2009
    Assignee: Eli Lilly and Company
    Inventors: Michael Joseph Coghlan, Prabhakar Kondaji Jadhav, James Joseph Droste, Jonathan Edward Green, Donald Paul Matthews
  • Patent number: 7411072
    Abstract: The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula: or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: August 12, 2008
    Assignee: Eli Lilly and Company
    Inventors: Michael Joseph Coghlan, Jonathan Edward Green, Timothy Alan Grese, Prabhakar Kondaji Jadhav, Donald Paul Matthews, Mitchell Irvin Steinberg, Kevin Robert Fales, Michael Gregory Bell
  • Publication number: 20080167310
    Abstract: The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.
    Type: Application
    Filed: October 3, 2007
    Publication date: July 10, 2008
    Inventors: Lynn Stacy Gossett, Jonathan Edward Green, James Robert Henry, Winton Dennis Jones, Donald Paul Matthews, Quanrong Shen, Daryl Lynn Smith, Jennifer Ann Vance, Alan M. Warshawsky, Maria Rosario Gonzalez-Garcia
  • Publication number: 20070292928
    Abstract: Production of ethanol in a thermophilic bacterium can be achieved by transformation of the bacterium with a heterologous gene encoding pyruvate decarboxylase. The bacterium comprises native alcohol dehydrogenase function and does not comprise a gene encoding a functional lactate dehydrogenase. The bacterium may be grown at elevated temperatures to allow the ethanol to be conveniently removed in a vaporized form from the fermentation medium. Traditional mesophilic microorganisms are incapable of growth at the envisioned elevated temperatures.
    Type: Application
    Filed: March 13, 2007
    Publication date: December 20, 2007
    Inventors: Edward Green, Muhammad Javed, Namdar Baghaei-Yazdi
  • Patent number: D561745
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: February 12, 2008
    Assignee: Zeus Antenna LLP
    Inventor: Edward A. Green
  • Patent number: D561746
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: February 12, 2008
    Assignee: Zeus Antenna LLP
    Inventor: Edward A. Green